My HPRA: Register

GEMCITABINE

38 Mg/Ml Concentrate for Soln for Inf

Fresenius Kabi Oncology PlcPA1422/003/005

Main Information

Trade NameGEMCITABINE
Active SubstancesGEMCITABINE HYDROCHLORIDE
Strength38 Mg/Ml
Dosage FormConcentrate for Soln for Inf
Licence HolderFresenius Kabi Oncology Plc
Licence NumberPA1422/003/005

Group Information

ATC CodeL01BC05 Pyrimidine analogues

Status

Authorised/WithdrawnAuthorised
Licence Issued16/01/2015
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings